James S Miser

Summary

Affiliation: City of Hope National Medical Center
Country: USA

Publications

  1. ncbi request reprint Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study
    James S Miser
    City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA 91010, USA
    J Clin Oncol 22:2873-6. 2004
  2. ncbi request reprint Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group
    James S Miser
    Division of Pediatrics, Department of Pediatric Hematology Oncology, City of Hope National Medical Center, Duarte, California 91010, USA
    Pediatr Blood Cancer 49:894-900. 2007
  3. pmc Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group
    Smita Bhatia
    Division of Pediatric Oncology, City of Hope National Medical Center, Duarte, CA, USA
    Blood 109:46-51. 2007
  4. ncbi request reprint Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
    Holcombe E Grier
    Department of Pediatric Hematology, Dana Farber Cancer Institute and Children s Hospital, Boston, MA 02115, USA
    N Engl J Med 348:694-701. 2003
  5. ncbi request reprint Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group
    Torunn I Yock
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Oncol 24:3838-43. 2006
  6. pmc Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy
    Robert C Shamberger
    Department of Surgery, Children s Hospital Boston, MA 02115, USA
    Ann Surg 238:563-7; discussion 567-8. 2003

Detail Information

Publications6

  1. ncbi request reprint Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study
    James S Miser
    City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA 91010, USA
    J Clin Oncol 22:2873-6. 2004
    ....
  2. ncbi request reprint Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group
    James S Miser
    Division of Pediatrics, Department of Pediatric Hematology Oncology, City of Hope National Medical Center, Duarte, California 91010, USA
    Pediatr Blood Cancer 49:894-900. 2007
    ..We evaluated whether a dose-intensity chemotherapy regimen improved survival for patients with ESFTs of bone with metastases at diagnosis...
  3. pmc Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group
    Smita Bhatia
    Division of Pediatric Oncology, City of Hope National Medical Center, Duarte, CA, USA
    Blood 109:46-51. 2007
    ..Increasing exposure to ifosfamide from 90 to 140 g/m2, cyclophosphamide from 9.6 to 17.6 g/m2, and doxorubicin from 375 to 450 mg/m2 increased the risk of t-MDS/AML significantly...
  4. ncbi request reprint Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
    Holcombe E Grier
    Department of Pediatric Hematology, Dana Farber Cancer Institute and Children s Hospital, Boston, MA 02115, USA
    N Engl J Med 348:694-701. 2003
    ..We designed a study to test whether the addition of these drugs to a standard regimen would improve the survival of patients with newly diagnosed disease...
  5. ncbi request reprint Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group
    Torunn I Yock
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Oncol 24:3838-43. 2006
    ..We investigated the relationship between the type of local control modality, surgery, radiation (RT) or both (S + RT), and subsequent risk for local failure (LF) in patients with nonmetastatic pelvic Ewing sarcoma treated on INT-0091...
  6. pmc Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy
    Robert C Shamberger
    Department of Surgery, Children s Hospital Boston, MA 02115, USA
    Ann Surg 238:563-7; discussion 567-8. 2003
    ..To establish outcome and optimal timing of local control for patients with nonmetastatic Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) of the chest wall...